Cancer

我们是谁

  • 1 月 9, 2024
    DETERMINE Trial Treatment Arm 2: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
  • 4 月 5, 2022
    BMS-986253与Nivolumab或Nivolumab加Ipilimumab联合治疗晚期癌症的研究
  • 4 月 5, 2022
    药物再发现方案（DRUP 试验）
  • 4 月 5, 2022
    Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
  • 4 月 5, 2022
    Adoptive Cell Therapy Across Cancer Diagnoses